Newsroom


Pfizer sues Trump administration over anti-kickback rules, saying they prevent it from helping lower seniors’ drug costs

Pfizer sues Trump administration over anti-kickback rules, saying they prevent it from helping lower seniors’ drug costs

By Nicholas Florko

Washington – June 26, 2020 – Pharmaceutical giant Pfizer is suing the Trump administration over two long-standing Medicare rules that Pfizer says are blocking it from helping seniors pay for an expensive heart condition drug.

If you would like to see the full article, contact us at info@amyloidosis.org.